Organization: Health Canada

Tune in, turn on, and lead in psychedelic-assisted therapy

Canada can be a leader in delivering widespread, well-regulated psychedelic-assisted therapy for people with depression, anxiety, post-traumatic stress disorder and substance abuse, by investing in research, educating health care professionals and providing the necessary clinical infrastructure, Dr. Ross Marshall, chief scientific officer at The Newly Institute based in Calgary, says in an op-ed.

The Short Report – June 28, 2022: Anand’s NORAD upgrade plans for space-based surveillance system; new funding streams strengthen Canada’s clinical trials; CIFAR launches Phase 2 of the Pan-Canadian Artificial Intelligence Strategy, and more.

NORAD upgrades include plans for a space-based surveillance system and a science program with the US; three new funding streams to bolster Canada’s clinical trials, phase 2 of the Pan-Canadian Artificial Intelligence Strategy launches, and more.

Debating decrim: hard drugs and hard decisions

Researchers are touting B.C.’s pilot initiative to decriminalize hard drug possession as a model to be applied across the country. They suggest studies to determine the efficacy of this approach to managing the harmful effect of addiction.